UNSPSC 51341501: Amprenavir

This classification denotes a protease inhibitor with the molecular formula C25H35N3O6S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5S0W860XNR, chemically known as 4-amino-n-((2 syn,3s)-2-hydroxy-4-phenyl-3-((s)-tetrahydrofuran-3-yloxycarbonylamino)-butyl)-n-isobutyl-benzenesulfonamide but generally known as amprenavir, which bears US NIH Compound Identifier 65016. Amprenavir most often comes in base, phosphate, and phosphate calcium forms.

UNSPSC 51341501 Amprenavir is a Commodity code that nominally covers a single antiretroviral pharmaceutical product, but recent state and local opportunities show the code being applied to broader pharmaceutical procurement — including antibiotics, naloxone, and drug deactivation systems — rather than amprenavir specifically. State and local health departments and county public health bodies are using this code to solicit pharmaceutical supplies through competitive bidding, including both open bids and piggyback arrangements via cooperative purchasing consortia. The solicitations reflect routine acquisition of essential medicines and harm-reduction supplies for public health operations, with delivery and storage requirements tied to specific county or state health facilities.

Recent activity appears concentrated in Florida and Illinois. The Illinois Department of Public Health awarded a piggyback contract through the MMCAP Infuse consortium to Chartwell Rx LLC on August 28, 2026 (Solicitation 26482DPHPREPDB53392) for Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg tablets under an Invitation for Bid process, with a total award of $2,999,999.11 over three years including renewals. Seminole County, Florida issued an Invitation for Bid (IFB60459723LAS, posted June 30, 2026) for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually, with quarterly deliveries required to the Seminole County Community Health Building in Sanford; the bid deadline was July 26, 2023. Both procurements require vendors to absorb shipping and delivery costs and comply with federal compliance frameworks when applicable.